Interview with the President and CEO: Inhibikase Therapeutics, Inc. (NASDAQ:IKT)August 22, 2022Werner, Milton
Interview with the President and CEO: Inhibikase Therapeutics, Inc. (NASDAQ:IKT)September 30, 2021Werner, Milton
First Name
Last Name
Email Address
Password
Confirm Password
Register
or create an account with a social network.
Username or Email address:
Password:
Log in
Forgot password?
or login using a social network
